# RXO, Inc.: financial statements, quarterly

RXO · NYSE · CIK 1929561 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rxo.md) · [Financials](/companies/rxo/financials.md) · [Filings](/companies/rxo/filings.md) · [Insiders](/companies/rxo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rxo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [978 d](/filings/0001929561-26-000013.md) | [913](/filings/0001929561-25-000082.md) | [930](/filings/0001929561-25-000102.md) | [1,040](/filings/0001929561-25-000113.md) | [1,667 d](/filings/0001929561-26-000013.md) | [1,433](/filings/0001929561-26-000026.md) | [1,419](/filings/0001929561-26-000036.md) | [1,421](/filings/0001929561-26-000049.md) | [1,469 d](/filings/0001929561-26-000013.md) | [1,425](/filings/0001929561-26-000026.md) | [1,774](/filings/0001929561-26-000036.md) | [1,871](/filings/0001929561-26-000049.md) |
| Selling, general and administrative | $m | [146 d](/filings/0001929561-26-000013.md) | [145](/filings/0001929561-25-000082.md) | [154](/filings/0001929561-25-000102.md) | [149](/filings/0001929561-25-000113.md) | [218 d](/filings/0001929561-26-000013.md) | [210](/filings/0001929561-26-000026.md) | [214](/filings/0001929561-26-000036.md) | [208](/filings/0001929561-26-000049.md) | [200 d](/filings/0001929561-26-000013.md) | [197](/filings/0001929561-26-000026.md) | [211](/filings/0001929561-26-000036.md) | [223](/filings/0001929561-26-000049.md) |
| Operating income | $m | [14.0 d](/filings/0001929561-26-000013.md) | [(12.0)](/filings/0001929561-25-000082.md) | [0.0](/filings/0001929561-25-000102.md) | [(20.0)](/filings/0001929561-25-000113.md) | [(24.0) d](/filings/0001929561-26-000013.md) | [(30.0)](/filings/0001929561-26-000026.md) | [0.0](/filings/0001929561-26-000036.md) | [(7.0)](/filings/0001929561-26-000049.md) | [(42.0) d](/filings/0001929561-26-000013.md) | [(28.0)](/filings/0001929561-26-000026.md) | [1.0](/filings/0001929561-26-000036.md) | [17.0](/filings/0001929561-26-000049.md) |
| Income tax | $m | [2.0 d](/filings/0001929561-26-000013.md) | [(6.0)](/filings/0001929561-25-000082.md) | [(1.0)](/filings/0001929561-25-000102.md) | [1.0](/filings/0001929561-25-000113.md) | [(8.0) d](/filings/0001929561-26-000013.md) | [(8.0)](/filings/0001929561-26-000026.md) | [(1.0)](/filings/0001929561-26-000036.md) | [(1.0)](/filings/0001929561-26-000049.md) | [(5.0) d](/filings/0001929561-26-000013.md) | [(13.0)](/filings/0001929561-26-000026.md) | [1.0](/filings/0001929561-26-000036.md) | [3.0](/filings/0001929561-26-000049.md) |
| Net income | $m | [2.0 d](/filings/0001929561-26-000013.md) | [(15.0)](/filings/0001929561-25-000082.md) | [(7.0)](/filings/0001929561-25-000102.md) | [(243)](/filings/0001929561-25-000113.md) | [(25.0) d](/filings/0001929561-26-000013.md) | [(31.0)](/filings/0001929561-26-000026.md) | [(9.0)](/filings/0001929561-26-000036.md) | [(14.0)](/filings/0001929561-26-000049.md) | [(46.0) d](/filings/0001929561-26-000013.md) | [(36.0)](/filings/0001929561-26-000026.md) | [(9.0)](/filings/0001929561-26-000036.md) | [3.0](/filings/0001929561-26-000049.md) |
| Diluted EPS | $ per share | not reported | [(0.13)](/filings/0001929561-25-000082.md) | [(0.06)](/filings/0001929561-25-000102.md) | [(1.81)](/filings/0001929561-25-000113.md) | not reported | [(0.18)](/filings/0001929561-26-000026.md) | [(0.05)](/filings/0001929561-26-000036.md) | [(0.08)](/filings/0001929561-26-000049.md) | not reported | [(0.21)](/filings/0001929561-26-000026.md) | [(0.05)](/filings/0001929561-26-000036.md) | [0.02](/filings/0001929561-26-000049.md) |
| Basic EPS | $ per share | not reported | [(0.13)](/filings/0001929561-25-000082.md) | [(0.06)](/filings/0001929561-25-000102.md) | [(1.81)](/filings/0001929561-25-000113.md) | not reported | [(0.18)](/filings/0001929561-26-000026.md) | [(0.05)](/filings/0001929561-26-000036.md) | [(0.08)](/filings/0001929561-26-000049.md) | not reported | [(0.21)](/filings/0001929561-26-000026.md) | [(0.05)](/filings/0001929561-26-000036.md) | [0.02](/filings/0001929561-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.0](/filings/0001929561-25-000044.md) | [7.0](/filings/0001929561-24-000082.md) | [7.0](/filings/0001929561-24-000102.md) | [55.0](/filings/0001929561-24-000127.md) | [35.0](/filings/0001929561-26-000013.md) | [16.0](/filings/0001929561-25-000082.md) | [18.0](/filings/0001929561-25-000102.md) | [25.0](/filings/0001929561-25-000113.md) | [17.0](/filings/0001929561-26-000049.md) | [21.0](/filings/0001929561-26-000026.md) | [15.0](/filings/0001929561-26-000036.md) | [25.0](/filings/0001929561-26-000049.md) |
| Current assets | $m | [796](/filings/0001929561-25-000044.md) | [770](/filings/0001929561-24-000082.md) | [776](/filings/0001929561-24-000102.md) | [1,255](/filings/0001929561-24-000127.md) | [1,339](/filings/0001929561-26-000013.md) | [1,255](/filings/0001929561-25-000082.md) | [1,184](/filings/0001929561-25-000102.md) | [1,201](/filings/0001929561-25-000113.md) | [1,317](/filings/0001929561-26-000049.md) | [1,335](/filings/0001929561-26-000026.md) | [1,556](/filings/0001929561-26-000036.md) | [1,607](/filings/0001929561-26-000049.md) |
| Total assets | $m | [1,825](/filings/0001929561-25-000044.md) | [1,799](/filings/0001929561-24-000082.md) | [1,813](/filings/0001929561-24-000102.md) | [3,392](/filings/0001929561-24-000127.md) | [3,414](/filings/0001929561-26-000013.md) | [3,304](/filings/0001929561-25-000082.md) | [3,201](/filings/0001929561-25-000102.md) | [3,201](/filings/0001929561-25-000113.md) | [3,277](/filings/0001929561-26-000049.md) | [3,268](/filings/0001929561-26-000026.md) | [3,459](/filings/0001929561-26-000036.md) | [3,496](/filings/0001929561-26-000049.md) |
| Current liabilities | $m | [682](/filings/0001929561-25-000044.md) | [674](/filings/0001929561-24-000082.md) | [662](/filings/0001929561-24-000102.md) | [947](/filings/0001929561-24-000127.md) | [1,065](/filings/0001929561-26-000013.md) | [964](/filings/0001929561-25-000082.md) | [880](/filings/0001929561-25-000102.md) | [907](/filings/0001929561-25-000113.md) | [1,038](/filings/0001929561-26-000049.md) | [1,048](/filings/0001929561-26-000026.md) | [1,227](/filings/0001929561-26-000036.md) | [1,255](/filings/0001929561-26-000049.md) |
| Current portion of debt | $m | [3.0](/filings/0001929561-25-000044.md) | [16.0](/filings/0001929561-24-000082.md) | [16.0](/filings/0001929561-24-000102.md) | [15.0](/filings/0001929561-24-000127.md) | [17.0](/filings/0001929561-26-000013.md) | [17.0](/filings/0001929561-25-000082.md) | [16.0](/filings/0001929561-25-000102.md) | [16.0](/filings/0001929561-25-000113.md) | [17.0](/filings/0001929561-26-000049.md) | [17.0](/filings/0001929561-26-000026.md) | [36.0](/filings/0001929561-26-000036.md) | [35.0](/filings/0001929561-26-000049.md) |
| Shareholders' equity | $m | [594](/filings/0001929561-26-000013.md) | [582](/filings/0001929561-25-000102.md) | [579](/filings/0001929561-25-000113.md) | [1,652](/filings/0001929561-25-000113.md) | [1,612](/filings/0001929561-26-000049.md) | [1,587](/filings/0001929561-26-000036.md) | [1,588](/filings/0001929561-26-000049.md) | [1,580](/filings/0001929561-26-000049.md) | [1,541](/filings/0001929561-26-000049.md) | [1,509](/filings/0001929561-26-000036.md) | [1,506](/filings/0001929561-26-000049.md) | [1,516](/filings/0001929561-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.0 d](/filings/0001929561-26-000013.md) | [7.0](/filings/0001929561-25-000082.md) | [(5.0) d](/filings/0001929561-25-000102.md) | [(7.0) d](/filings/0001929561-25-000113.md) | [(7.0) d](/filings/0001929561-26-000013.md) | [(2.0)](/filings/0001929561-26-000026.md) | [23.0 d](/filings/0001929561-26-000036.md) | [23.0 d](/filings/0001929561-26-000049.md) | [7.0 d](/filings/0001929561-26-000013.md) | [(7.0)](/filings/0001929561-26-000026.md) | [(40.0) d](/filings/0001929561-26-000036.md) | [25.0 d](/filings/0001929561-26-000049.md) |
| Capital expenditure | $m | [18.0 d](/filings/0001929561-26-000013.md) | [11.0](/filings/0001929561-25-000082.md) | [11.0 d](/filings/0001929561-25-000102.md) | [11.0 d](/filings/0001929561-25-000113.md) | [12.0 d](/filings/0001929561-26-000013.md) | [15.0](/filings/0001929561-26-000026.md) | [14.0 d](/filings/0001929561-26-000036.md) | [14.0 d](/filings/0001929561-26-000049.md) | [16.0 d](/filings/0001929561-26-000013.md) | [17.0](/filings/0001929561-26-000026.md) | [12.0 d](/filings/0001929561-26-000036.md) | [13.0 d](/filings/0001929561-26-000049.md) |
| Share repurchases | $m | [0.0 d](/filings/0001929561-26-000013.md) | not reported | not reported | [0.0 d](/filings/0001929561-24-000127.md) | [0.0 d](/filings/0001929561-26-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [119](/filings/0001929561-24-000082.md) | [119](/filings/0001929561-24-000102.md) | [117](/filings/0001929561-24-000127.md) | [117](/filings/0001929561-25-000082.md) | [118](/filings/0001929561-25-000102.md) | [134](/filings/0001929561-25-000113.md) | [168](/filings/0001929561-26-000026.md) | [169](/filings/0001929561-26-000036.md) | [169](/filings/0001929561-26-000049.md) | [169](/filings/0001929561-26-000026.md) | [170](/filings/0001929561-26-000036.md) | [172](/filings/0001929561-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 164,951,056 at 2026-10-27, from the cover of the [10-Q filed 2026-10-29](/filings/0001929561-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:07 ET. No prices; not investment advice.